ARTICLE | Financial News
Selecta prices $70M IPO
June 22, 2016 11:53 PM UTC
Immunomodulatory company Selecta Biosciences Inc. (NASDAQ:SELB) was unchanged its first day of trading Wednesday after raising $70 million through the sale of 5 million shares at $14 in an IPO. The price valued Selecta at $247.3 million.
The company filed in May to raise up to $75 million. Earlier this month, Selecta said it hoped to sell 4.3 million shares at $14-$16. UBS, Stifel, Canaccord and Needham are underwriters. ...